Cambridge, MA
Biobot Analytics develops cutting-edge technology to transform sewers into public health observatories. Wastewater contains valuable information about the health of communities. We collect it. We analyze it. We tell you how to leverage it to make your city better. Our first product is to measure opioids and other drug metabolites in sewage to estimate consumption in cities. With this data, those working on harm reduction can assess the scope of the epidemic, allocate resources, and gauge the effectiveness of programming over time.
http://www.biobot.io/These are collections Biobot is a part of. Click on the collection name to view similar companies.
Series A
$13,400,000
Series A
$20,833,737
Seed
$4,200,000
Seed
$2,500,000
Pre Seed
$120,000
Pre Seed
$345,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Biobot.